Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 1
2010 1
2011 2
2012 2
2014 2
2015 2
2016 3
2017 3
2018 3
2019 2
2020 2
2021 7
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma.
Haas L, Elewaut A, Gerard CL, Umkehrer C, Leiendecker L, Pedersen M, Krecioch I, Hoffmann D, Novatchkova M, Kuttke M, Neumann T, da Silva IP, Witthock H, Cuendet MA, Carotta S, Harrington KJ, Zuber J, Scolyer RA, Long GV, Wilmott JS, Michielin O, Vanharanta S, Wiesner T, Obenauf AC. Haas L, et al. Among authors: cuendet ma. Nat Cancer. 2021 Jul;2(7):693-708. doi: 10.1038/s43018-021-00221-9. Epub 2021 Jul 15. Nat Cancer. 2021. PMID: 35121945 Free PMC article.
Structural Prediction of Peptide-MHC Binding Modes.
Perez MAS, Cuendet MA, Röhrig UF, Michielin O, Zoete V. Perez MAS, et al. Among authors: cuendet ma. Methods Mol Biol. 2022;2405:245-282. doi: 10.1007/978-1-0716-1855-4_13. Methods Mol Biol. 2022. PMID: 35298818 Review.
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy.
Courlet P, Abler D, Guidi M, Girard P, Amato F, Vietti Violi N, Dietz M, Guignard N, Wicky A, Latifyan S, De Micheli R, Jreige M, Dromain C, Csajka C, Prior JO, Venkatakrishnan K, Michielin O, Cuendet MA, Terranova N. Courlet P, et al. Among authors: cuendet ma. CPT Pharmacometrics Syst Pharmacol. 2023 Aug;12(8):1170-1181. doi: 10.1002/psp4.12983. Epub 2023 Jun 16. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37328961 Free PMC article.
A differential process mining analysis of COVID-19 management for cancer patients.
Cuendet MA, Gatta R, Wicky A, Gerard CL, Dalla-Vale M, Tavazzi E, Michielin G, Delyon J, Ferahta N, Cesbron J, Lofek S, Huber A, Jankovic J, Demicheli R, Bouchaab H, Digklia A, Obeid M, Peters S, Eicher M, Pradervand S, Michielin O. Cuendet MA, et al. Front Oncol. 2022 Dec 7;12:1043675. doi: 10.3389/fonc.2022.1043675. eCollection 2022. Front Oncol. 2022. PMID: 36568192 Free PMC article.
Unusual mode of dimerization of retinitis pigmentosa-associated F220C rhodopsin.
Khelashvili G, Pillai AN, Lee J, Pandey K, Payne AM, Siegel Z, Cuendet MA, Lewis TR, Arshavsky VY, Broichhagen J, Levitz J, Menon AK. Khelashvili G, et al. Among authors: cuendet ma. Sci Rep. 2021 May 18;11(1):10536. doi: 10.1038/s41598-021-90039-3. Sci Rep. 2021. PMID: 34006992 Free PMC article.
38 results